A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System
Part of paid clinical trials in Tucson, Arizona.
- Sponsor
- Zimmer Biomet
- Study ID
- NCT02036931
- Status
- Completed
Conditions
- Noninflammatory Degenerative Joint Disease
- Rheumatoid Arthritis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Metal on Polyethylene articulation — DEVICEG7 Acetabular Cup System with Metal head on Polyethylene liner articulation (MOP)
- Ceramic on Polyethylene articulation — DEVICEG7 Acetabular Cup System with Ceramic head on Polyethylene liner articulation (COP)
- Ceramic on Ceramic articulation — DEVICEG7 Acetabular Cup System with Ceramic head on Ceramic linear articulation (COC) - Outside the United States ONLY
Study Details
This is a prospective observational multi-center non-controlled study. The primary purpose of this study is to evaluate the clinical and radiographic performance of the G7 Acetabular Cup System.
Key Dates
- Start date
- Mar 31, 2013
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2024
- Completion
- May 31, 2025
Study Design
- Enrollment
- 162 participants (actual)
Arms
- Arm: Metal on Polyethylene articulationG7 cup with Metal on Polyethylene articulation (MOP)
- Arm: Ceramic on Polyethylene articulationG7 cup with Ceramic on Polyethylene articulation (COP)
- Arm: Ceramic on Ceramic articulationG7 cup with Ceramic on Ceramic articulation (COC)
Primary Outcome Measure
Harris Hip Score [ Time Frame: Pre-operative,1, 2, and 5 years postoperatively ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University Orthopedic Specialists | Tucson | Arizona | 85718 | - |
Find similar trials in Tucson, AZ
By condition
By research site
Related Studies
- RA-PRO PRAGMATIC TRIALPHASE3 · Recruiting · University of Alabama at Birmingham · Auburn, Alabama
- Study of Single Doses of SBT777101 in Subjects With Rheumatoid ArthritisPHASE1 · Recruiting · Sonoma Biotherapeutics, Inc. · Scottsdale, Arizona
- A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisPHASE2 · Recruiting · AbbVie · Peoria, Arizona
- A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)PHASE2 · Recruiting · Hoffmann-La Roche · Peoria, Arizona